Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-08-16
2005-08-16
Carlson, Karen Cochrane (Department: 1653)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C530S350000
Reexamination Certificate
active
06929919
ABSTRACT:
Presenilin Associated Membrane Protein (PAMP), and nucleic acids encoding this protein, are provided. PAMP and PAMP nucleic acids provide diagnostic and therapeutic tools for evaluating and treating or preventing neurodevelopmental and neuropsychiatric disorders. In a specific embodiment, mutations in PAMP are diagnostic for schizophrenia. The invention further relates to screening, particularly using high-throughput screens and transgenic animal models, for compounds that modulate the activity of PAMP and presenilins. Such compounds, or gene therapy with PAMP, can be used in treating neurodevelopmental and neuropsychiatric disorders, particularly schizophrenia. In addition, the invention provides PAMP mutants, nucleic acids encoding for PAMP mutants, and transgenic animals expressing PAMP mutants, which in a preferred aspect result in biochemical, morphological, or neuropsychological changes similar to those associated with schizophrenia.
REFERENCES:
patent: 5986054 (1999-11-01), St. George-Hyslop et al.
patent: 6020143 (2000-02-01), St. George-Hyslop et al.
patent: WO 00/60069 (2000-10-01), None
patent: WO 01/53312 (2001-07-01), None
patent: WO 01/67109 (2001-09-01), None
Nagase, T. et al.: “Prediction of the Coding Sequences of Unidentified Human Genes. VI. The Coding Sequences of 80 New Genes (KIAA0201-KIAA0280) Deduced by Analysis of cDNA Clones from Cell Line KG-1 and Brain” DNA Research, Universal Academy Press, JP, vol. 3, No. 5, 1996, pp. 321-329, XP000891809.
Database EMBL Onlinel, Nov. 9, 1996, Nagase et al.: “Human mRNA for KIAA0253 gene, partial cds” Database accession No. D87442, XP002206950.
Wei, J. et al.: “The NOTCH4 locus is associated with susceptibility to schizophrenia.” Nature Genetics. U. S., Aug. 2000, vol. 25, No. 4, pp. 376-377, XP002206948.
Chen, Fusheng et al.: “Nicastrin binds to membrane-tethered Notch.” Nature Cell Biology, vol. 3, No. 8, Aug. 2001, pp. 751-754, XP008006199.
International Search Report.
Baker, “Notch signaling in the nervous system. Pieces still missing from the puzzle”, Bioessays 2000; 22:264-273.
Borchelt et al., “Familial Alzheimer's Disease-Linked Presenilin 1 Variants Elevate Abeta 1-42/1-40 Ratio In Vitro and In Vivo”, Neuron 1996; 17:1005-1013.
Brzustowicz et al., “Location of a Major Susceptibility Locus for Familial Schizophrenia on Chromosome 1q21-q22”, Science 2000; 288:678-682.
Citron et al., “Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid B-protein in both transfected cells and transgenic mice”, Nature Med. 1997; 3:67-72.
DeStrooper et al., Nature 1998; 391:387-390.
Duff et al., “Increased amyloid-B42(43) in brains of mice expressing mutant presenilin 1”, Nature 1996; 383:710-713.
Falkai et a l., “Entorhinal Cortex Pre-Alpha Cell Clusters in Schizophrenia: Quantitative Evidence of a Developmental Abnormality”, Biol Psychiatry 2000; 47:937-943.
Handler et al., “Presenilin-1 regulates neuronal differentiation during neurogenesis”, Development 2000 Jun.;127(12):2593-2606.
Hartmann et al., “Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly”, Curr Biol 1999; 15:719-727.
Jones et al., “Mutation in codon 713 of the B amyloid precursor protein gene presenting with schizophrenia”, Nature Genet 1992; 1:306-309.
Levitan et al., “Facilitation of lin-12-mediated signalling by sel-12, aCaenorhabditis elegansS182 Alzheimer's disease gene”, Nature 1995; 377:351-354.
Martins et al., “High levels of amyloid-B protein from S182 (Glu246) familial Alzheimer's cells”, NeuroReport 1995; 7:217-220.
Scheuner et al., “Secreted amyloid B-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease”, Nature Med. 1996; 2:864-870.
Selkoe, Curr Opin Neurobiol 2000; 10:50-57.
Shen J. et al., “Sketetal and CNS Defects in Presenilin-1-Deficient Mice”, Cell 1997; 89:629-639.
Stefan and Murray, “Schizophrenia: developmental disturbance of brain and mind?”, Acta Paediatrica Suppl. 1997; 422:112-116.
Wei and Hemmings, “The NOTCH4 locus is associated with susceptibility to schizophrenia”, Nature Genet 2000; 25:376-377.
Wolozin et al., “Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by anAlzheimer Mutation”, Science 1996; 274:1710-1713.
Wong PC et al., “Presenilin 1 is required for Notch1 and Dll1 expression in the paraxial mesoderm”, Nature 1997; 387:288-292.
Yu et al., “Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and BAPP processing”, Nature 2000; 407:48-54.
Boulianne et al., “Cloning and characterization of theDrosophilapresenilin homologue”, Neuro. Report (Fast Track) 1997; 8:1025-1029.
Zhou et al., “Presenilin 1 interaction in the brain with a novel member of the Armadillo family”, Neuroreport 1997; 8:2085-2090.
Fraser Paul E.
St. George-Hyslop Peter H.
Carlson Karen Cochrane
Darby & Darby
The Governing Council of the University of Toronto
LandOfFree
Proteins related to schizophrenia and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteins related to schizophrenia and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteins related to schizophrenia and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3510009